Authors: McGrath, LT McGleenon, BM Brennan, S McColl, D McIlroy, S Passmore, AP

Citation: Lt. Mcgrath et al., Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde, QJM-MON J A, 94(9), 2001, pp. 485-490

Authors: McGleenon, BM Passmore, AP McAuley, DF Johnston, GD

Citation: Bm. Mcgleenon et al., No evidence of endothelial dysfunction in patients with Alzheimer's disease, DEMENT G C, 11(4), 2000, pp. 197-201

Authors: McIlroy, SP Crawford, VLS Dynan, KB McGleenon, BM Vahidassr, MD Lawson, JT Passmore, AP

Citation: Sp. Mcilroy et al., Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland, J MED GENET, 37(3), 2000, pp. 182-185

Authors: McGleenon, BM Dynan, KB Passmore, AP

Citation: Bm. Mcgleenon et al., Acetylcholinesterase inhibitors in Alzheimer's disease, BR J CL PH, 48(4), 1999, pp. 471-480

Authors: Mcllroy, SP Dynan, KB McGleenon, BM Lawson, JT Passmore, AP

Citation: Sp. Mcllroy et al., Cathepsin D gene exon 2 polymorphism and sporadic Alzheimer's disease, NEUROSCI L, 273(2), 1999, pp. 140-141